ZOLINZA Side Effects

6135888-X | Mucormycosis, Neuralgia, Neuropathy Peripheral, Somnolence, T-cell Lymphoma Recurrent
on May 20, 2008 Male patient from UNITED STATES , 15 years of age, weighting 156.5 lb, was diagnosed with t-cell lymphoma and was treated with Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: mucormycosis, neuralgia, neuropathy peripheral, somnolence, t-cell lymphoma recurrent. Zolinza dosage: . During the same period patient was treated with ALEMTUZUMAB (View Alemtuzumab Review and Alemtuzumab Label ), BORTEZOMIB (View Bortezomib Review and Bortezomib Label ), MEPERIDINE HYDROCHLORIDE (View Meperidine Hydrochloride Review and Meperidine Hydrochloride Label ), BACTRIM (View Bactrim Review and Bactrim Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized and became disabled.

6092469-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Mucosal Inflammation, Non-hodgkin's Lymphoma, Off Label Use
Patient was taking Zolinza (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, mucosal inflammation, non-hodgkin's lymphoma, off label use on Sep 24, 2007 from UNITED STATES Additional patient health information: Female patient , 53 years of age, weighting 169.8 lb, was diagnosed with non-hodgkin's lymphoma and. Zolinza dosage: . During the same period patient was treated with CYTOXAN (View Cytoxan Review and Cytoxan Label ), NEXAVAR (View Nexavar Review and Nexavar Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), BUPHENYL (View Buphenyl Review and Buphenyl Label ). Patient was hospitalized.

6085430-7 | Chills, Rash
Adverse event was reported on Dec 17, 2008 by a Female patient taking Zolinza (View Usage) (Dosage: 100 Mg/bid/po) was diagnosed with mycosis fungoides and. Location: UNITED STATES , 73 years of age, After Zolinza was administered, patient had the following side effects: chills, rash (What is rash?).

6085429-0 | Skin Hyperpigmentation
on Dec 05, 2008 Female patient from UNITED STATES , 61 years of age, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: skin hyperpigmentation. Zolinza dosage: .


6085427-7 | Chest Pain
on Nov 05, 2008 Male patient from UNITED STATES , 66 years of age, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). Patient had the following side effects: chest pain (What is chest pain?). Zolinza dosage: 400 Mg/daily/po. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6085420-4 | Anorexia, Asthenia, Dehydration, Fatigue, Haemorrhage, Hyperglycaemia, Open Wound
Patient was taking Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: anorexia, asthenia, dehydration, fatigue, haemorrhage, hyperglycaemia, open wound on Oct 08, 2008 from UNITED STATES Additional patient health information: Female patient , 86 years of age, weighting 128.0 lb, was diagnosed with mycosis fungoides and. Zolinza dosage: 400 Mg/daily/po.

6079310-0 | Acute Respiratory Distress Syndrome, Off Label Use, Pancytopenia, Sepsis
Adverse event was reported on Feb 10, 2009 by a Male patient taking Zolinza (View Usage) (Dosage: ) was diagnosed with brain neoplasm and. Location: UNITED STATES , 28 years of age, Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, off label use, pancytopenia, sepsis (What is sepsis?). During the same period patient was treated with NEXAVAR (View Nexavar Review and Nexavar Label ), RAPAMUNE (View Rapamune Review and Rapamune Label ). Patient was hospitalized.

6078308-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Mucosal Inflammation, Non-hodgkin's Lymphoma, Off Label Use
on Sep 24, 2007 Female patient from UNITED STATES , 53 years of age, weighting 169.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Zolinza (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, mucosal inflammation, non-hodgkin's lymphoma, off label use. Zolinza dosage: . During the same period patient was treated with CYTOXAN (View Cytoxan Review and Cytoxan Label ), NEXAVAR (View Nexavar Review and Nexavar Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), BUPHENYL (View Buphenyl Review and Buphenyl Label ). Patient was hospitalized.

6077561-2 | Acute Respiratory Distress Syndrome, Pancytopenia, Sepsis
on Feb 10, 2009 Male patient from UNITED STATES , 28 years of age, was diagnosed with brain neoplasm and was treated with Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: acute respiratory distress syndrome, pancytopenia, sepsis (What is sepsis?). Zolinza dosage: . During the same period patient was treated with NEXAVAR (View Nexavar Review and Nexavar Label ), RAPAMUNE (View Rapamune Review and Rapamune Label ). Patient was hospitalized.

5960275-4 | Diarrhoea, Dyspepsia, Fatigue, Transient Ischaemic Attack
Patient was taking Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, dyspepsia, fatigue, transient ischaemic attack on Sep 30, 2008 from UNITED STATES Additional patient health information: Female patient , 72 years of age, was diagnosed with mycosis fungoides and. Zolinza dosage: Po. During the same period patient was treated with ADVAIR HFA (View Advair Hfa Review and Advair Hfa Label ), ALLEGRA (View Allegra Review and Allegra Label ), FLONASE (View Flonase Review and Flonase Label ), LIPITOR (View Lipitor Review and Lipitor Label ), PREMARIN (View Premarin Review and Premarin Label ), PROTONIX (View Protonix Review and Protonix Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ).

5960270-5 | Anorexia, Diarrhoea, Dysgeusia, Fatigue, Headache, Nausea
Adverse event was reported on Jul 31, 2008 by a Male patient taking Zolinza (View Usage) (Dosage: 400 Mg/ Daily/ Po; 300 Mg/ 5xw/po; 300 Mg/ Daily/ Po) was diagnosed with mycosis fungoides and. Location: UNITED STATES , 39 years of age, weighting 205.0 lb, Patient had the following side effects: anorexia, diarrhoea, dysgeusia, fatigue, headache (What is headache?), nausea (What is nausea?). During the same period patient was treated with ADVAIR HFA (View Advair Hfa Review and Advair Hfa Label ), SINGULAIR (View Singulair Review and Singulair Label ).

5960251-1 | Blood Bilirubin Increased, Platelet Count Decreased, Skin Lesion
on Jul 09, 2008 Male patient from UNITED STATES , 74 years of age, was diagnosed with t-cell lymphoma and was treated with Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: blood bilirubin increased, platelet count decreased, skin lesion. Zolinza dosage: 400 Mg/ Daily.

5958986-X | Adverse Event, Headache, Neutropenia, White Blood Cell Count Decreased
on Jul 16, 2008 Female patient from UNITED STATES , 55 years of age, weighting 123.0 lb, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: adverse event, headache (What is headache?), neutropenia, white blood cell count decreased. Zolinza dosage: 400 Mg/daily/po. Patient was hospitalized.

5940541-9 | Deafness, Weight Decreased
Patient was taking Zolinza (View Usage). Patient had the following side effects: deafness, weight decreased on Oct 28, 2008 from UNITED STATES Additional patient health information: Male patient , 64 years of age, weighting 176.4 lb, was diagnosed with mycosis fungoides, lipids increased and. Zolinza dosage: . During the same period patient was treated with INTRON A (View Intron A Review and Intron A Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LUNESTA (View Lunesta Review and Lunesta Label ), TRICOR (View Tricor Review and Tricor Label ).

5935981-8 | Anaemia, Tumour Necrosis, White Blood Cell Count Decreased
Adverse event was reported on Oct 23, 2008 by a Male patient taking Zolinza (View Usage) (Dosage: ) was diagnosed with t-cell lymphoma and. Location: UNITED STATES , 68 years of age, After Zolinza was administered, patient had the following side effects: anaemia, tumour necrosis, white blood cell count decreased. During the same period patient was treated with DOXIL (View Doxil Review and Doxil Label ), TARGRETIN (View Targretin Review and Targretin Label ). Patient was hospitalized.

5927368-9 | Abdominal Pain Lower, Back Pain, Deep Vein Thrombosis, Dizziness, Haemolysis, Hepatic Function Abnormal, Hypovolaemic Shock, Intra-abdominal Haemorrhage, Lymphadenopathy
on Dec 11, 2007 Female patient from UNITED STATES , 62 years of age, weighting 157.0 lb, was diagnosed with breast cancer metastatic and was treated with Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain lower, back pain (What is back pain?), deep vein thrombosis (What is deep vein thrombosis?), dizziness (What is dizziness?), haemolysis, hepatic function abnormal, hypovolaemic shock, intra-abdominal haemorrhage, lymphadenopathy. Zolinza dosage: 400 Mg Daily Po. During the same period patient was treated with TAMOXIFEN CITRATE (20 Mg Daily Po) (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), COMPAZINE (View Compazine Review and Compazine Label ), TAXUS (TAMOXIFEN CITRATE) (View Taxus (tamoxifen Citrate) Review and Taxus (tamoxifen Citrate) Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ). Patient was hospitalized.

5927265-9 | Anaemia, Tumour Necrosis, White Blood Cell Count Decreased
on Oct 14, 2008 Male patient from UNITED STATES , 68 years of age, was diagnosed with t-cell lymphoma and was treated with Zolinza (View Usage). Patient had the following side effects: anaemia, tumour necrosis, white blood cell count decreased. Zolinza dosage: . During the same period patient was treated with DOXIL (View Doxil Review and Doxil Label ), TARGRETIN (View Targretin Review and Targretin Label ). Patient was hospitalized.

5901642-4 | Ageusia, Anaemia, Anorexia, Blood Alkaline Phosphatase Increased, Chills, Cough, Cyst, Dehydration, Diabetic Ketoacidosis
Patient was taking Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: ageusia, anaemia, anorexia, blood alkaline phosphatase increased, chills, cough, cyst, dehydration, diabetic ketoacidosis on Mar 17, 2008 from UNITED STATES Additional patient health information: Male patient , 55 years of age, was diagnosed with mycosis fungoides stage ii and. Zolinza dosage: . During the same period patient was treated with FLUOCINOLONE ACETONIDE (View Fluocinolone Acetonide Review and Fluocinolone Acetonide Label ). Patient was hospitalized.

5891399-8 | Deafness, Weight Decreased
Adverse event was reported on Sep 18, 2008 by a Male patient taking Zolinza (View Usage) (Dosage: ) was diagnosed with mycosis fungoides, lipids increased and. Location: UNITED STATES , 64 years of age, Patient experienced the following unwanted or unexpected effects: deafness, weight decreased. During the same period patient was treated with INTRON A (View Intron A Review and Intron A Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LUNESTA (View Lunesta Review and Lunesta Label ), TRICOR (View Tricor Review and Tricor Label ).

5876742-8 | Cardio-respiratory Arrest
on Jul 16, 2007 Male patient from UNITED STATES , 56 years of age, weighting 167.6 lb, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). Patient had the following side effects: cardio-respiratory arrest. Zolinza dosage: . During the same period patient was treated with GEMCITABINE HYDROCHLORIDE (View Gemcitabine Hydrochloride Review and Gemcitabine Hydrochloride Label ), ADENOSINE (View Adenosine Review and Adenosine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), FLEBOGAMMA (View Flebogamma Review and Flebogamma Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

5851677-5 | Nausea
on Jun 04, 2008 Male patient from UNITED STATES , 45 years of age, was treated with Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: nausea (What is nausea?). Zolinza dosage: 400 Mg/daily/po.

5851672-6 | Bone Pain
Patient was taking Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: bone pain on Jun 02, 2008 from UNITED STATES Additional patient health information: Male patient , 60 years of age, was diagnosed with mycosis fungoides and. Zolinza dosage: 400 Mg/daily.

5851670-2 | Alopecia, Anorexia, Skin Lesion, Weight Decreased
Adverse event was reported on May 01, 2008 by a Male patient taking Zolinza (View Usage) (Dosage: 400 Mg/daily/po : 100 Mg/daily/po) was diagnosed with mycosis fungoides and. Location: UNITED STATES , 65 years of age, Patient had the following side effects: alopecia, anorexia, skin lesion, weight decreased. During the same period patient was treated with ENABLEX (View Enablex Review and Enablex Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

5851666-0 | Headache, Neutropenia
on Jun 12, 2008 Female patient from UNITED STATES , 55 years of age, weighting 123.0 lb, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: headache (What is headache?), neutropenia. Zolinza dosage: 400 Mg/ Daily/ Po. Patient was hospitalized.

5837719-1 | Hepatic Enzyme Increased, Mycosis Fungoides
on Aug 01, 2008 Male patient from UNITED STATES , 70 years of age, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased, mycosis fungoides. Zolinza dosage: . During the same period patient was treated with TARGRETIN (View Targretin Review and Targretin Label ).

5827226-4 | Hepatic Enzyme Increased, Mycosis Fungoides
Patient was taking Zolinza (View Usage). Patient had the following side effects: hepatic enzyme increased, mycosis fungoides on Jul 17, 2008 from UNITED STATES Additional patient health information: Male patient , 70 years of age, was diagnosed with mycosis fungoides and. Zolinza dosage: . During the same period patient was treated with TARGRETIN (View Targretin Review and Targretin Label ).

5782901-5 | Ageusia, Anaemia, Anorexia, Blood Alkaline Phosphatase Increased, Chills, Cough, Cyst, Dehydration, Diabetic Ketoacidosis
Adverse event was reported on Mar 17, 2008 by a Male patient taking Zolinza (View Usage) (Dosage: ) was diagnosed with mycosis fungoides stage ii and. Location: UNITED STATES , 55 years of age, After Zolinza was administered, patient had the following side effects: ageusia, anaemia, anorexia, blood alkaline phosphatase increased, chills, cough, cyst, dehydration, diabetic ketoacidosis. Patient was hospitalized.

5774623-1 | Ageusia, Anaemia, Anorexia, Blood Alkaline Phosphatase Increased, Chills, Cough, Cyst, Dehydration, Diabetic Ketoacidosis
on Mar 17, 2008 Male patient from UNITED STATES , 55 years of age, was diagnosed with mycosis fungoides stage ii and was treated with Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: ageusia, anaemia, anorexia, blood alkaline phosphatase increased, chills, cough, cyst, dehydration, diabetic ketoacidosis. Zolinza dosage: . Patient was hospitalized.

5749655-X | Atrial Fibrillation, Bacterial Sepsis, Cardiac Failure Congestive
on May 14, 2008 Male patient from UNITED STATES , 52 years of age, was diagnosed with acute myeloid leukaemia, chromosome analysis abnormal and was treated with Zolinza (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), bacterial sepsis, cardiac failure congestive. Zolinza dosage: . During the same period patient was treated with IDARUBICIN HYDROCHLORIDE (View Idarubicin Hydrochloride Review and Idarubicin Hydrochloride Label ), SJG 136 (View Sjg-136 Review and Sjg-136 Label ).

5747851-9 | Adverse Event, Mucormycosis, Neuralgia, Neuropathy Peripheral, T-cell Lymphoma Recurrent
Patient was taking Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: adverse event, mucormycosis, neuralgia, neuropathy peripheral, t-cell lymphoma recurrent on May 20, 2008 from UNITED STATES Additional patient health information: Male patient , 15 years of age, weighting 156.5 lb, was diagnosed with t-cell lymphoma and. Zolinza dosage: . During the same period patient was treated with ALEMTUZUMAB (View Alemtuzumab Review and Alemtuzumab Label ), BORTEZOMIB (View Bortezomib Review and Bortezomib Label ), MEPERIDINE HYDROCHLORIDE (View Meperidine Hydrochloride Review and Meperidine Hydrochloride Label ), BACTRIM (View Bactrim Review and Bactrim Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized and became disabled.

5742209-0 | Eye Swelling, Ocular Hyperaemia, Rash, Skin Exfoliation
Adverse event was reported on Mar 20, 2008 by a Female patient taking Zolinza (View Usage) (Dosage: 400 Mg/daily/po) was diagnosed with mycosis fungoides and. Location: UNITED STATES , 76 years of age, Patient experienced the following unwanted or unexpected effects: eye swelling, ocular hyperaemia, rash (What is rash?), skin exfoliation.

5742200-4 | Alopecia, Blood Bilirubin Increased, Dysgeusia
on Feb 27, 2008 Female patient from UNITED STATES , 48 years of age, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). Patient had the following side effects: alopecia, blood bilirubin increased, dysgeusia. Zolinza dosage: 300 Mg/daily/po; 400 Mg/daily/po. During the same period patient was treated with POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ).

5684455-0 | Acidosis, Anorexia, Chills, Cough, Dehydration, Dysuria, Fatigue, Feeling Abnormal, Headache
on Mar 17, 2008 Male patient from UNITED STATES , 55 years of age, was diagnosed with mycosis fungoides stage ii and was treated with Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: acidosis, anorexia, chills, cough, dehydration, dysuria, fatigue, feeling abnormal, headache (What is headache?). Zolinza dosage: . Patient was hospitalized.

5662083-0 | Erythema, Nausea, Pruritus, Rash, Skin Burning Sensation, Swelling, Urticaria
Patient was taking Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, nausea (What is nausea?), pruritus, rash (What is rash?), skin burning sensation, swelling, urticaria on Oct 29, 2007 from UNITED STATES Additional patient health information: Male patient , 80 years of age, weighting 183.0 lb, was diagnosed with non-hodgkin's lymphoma and. Zolinza dosage: 400 Mg/daily/po.

5662071-4 | Anorexia, Dehydration, Pruritus
Adverse event was reported on Oct 09, 2007 by a Female patient taking Zolinza (View Usage) (Dosage: 100 Mg/bid/po) . Location: UNITED STATES , 88 years of age, Patient had the following side effects: anorexia, dehydration, pruritus. During the same period patient was treated with ATARAX (View Atarax Review and Atarax Label ).

5661463-7 | Adverse Event, Neuropathy Peripheral, T-cell Lymphoma Recurrent
on Mar 10, 2008 Male patient from UNITED STATES , 15 years of age, was diagnosed with t-cell lymphoma and was treated with Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: adverse event, neuropathy peripheral, t-cell lymphoma recurrent. Zolinza dosage: . During the same period patient was treated with ALEMTUZUMAB (View Alemtuzumab Review and Alemtuzumab Label ), BORTEZOMIB (View Bortezomib Review and Bortezomib Label ), MEPERIDINE HYDROCHLORIDE (View Meperidine Hydrochloride Review and Meperidine Hydrochloride Label ), BACTRIM (View Bactrim Review and Bactrim Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

5651148-5 | Neuropathy Peripheral, T-cell Lymphoma Recurrent
on Feb 28, 2008 Male patient from UNITED STATES , 15 years of age, was diagnosed with t-cell lymphoma and was treated with Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: neuropathy peripheral, t-cell lymphoma recurrent. Zolinza dosage: . During the same period patient was treated with ALEMTUZUMAB (View Alemtuzumab Review and Alemtuzumab Label ), BORTEZOMIB (View Bortezomib Review and Bortezomib Label ), MEPERIDINE HYDROCHLORIDE (View Meperidine Hydrochloride Review and Meperidine Hydrochloride Label ), BACTRIM (View Bactrim Review and Bactrim Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

5636879-5 | Blood Thyroid Stimulating Hormone Increased, Cerebral Atrophy, Constipation, Dehydration, Dizziness, Dyspnoea, Hypermagnesaemia, Nausea, Oral Fungal Infection
Patient was taking Zolinza (View Usage). Patient had the following side effects: blood thyroid stimulating hormone increased, cerebral atrophy, constipation (What is constipation?), dehydration, dizziness (What is dizziness?), dyspnoea, hypermagnesaemia, nausea (What is nausea?), oral fungal infection on Feb 05, 2008 from DENMARK Additional patient health information: Female patient , 77 years of age, was diagnosed with ovarian epithelial cancer recurrent and. Zolinza dosage: 100 Mg/daily; Po. During the same period patient was treated with CARBOPLATIN (425 Mg; Iv) (View Carboplatin Review and Carboplatin Label ), PACLITAXEL (300 Mg; Iv) (View Paclitaxel Review and Paclitaxel Label ), MG OXIDE (View Mg Oxide Review and Mg Oxide Label ), METOCLOPRAMIDE HYDROCHLORIDE (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ), ONDANSETRON HYDROCHLORIDE (View Ondansetron Hydrochloride Review and Ondansetron Hydrochloride Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

5621696-2 | Abdominal Pain Lower, Asthenia, Back Pain, Blood Bilirubin Increased, Blood Potassium Increased, Blood Pressure Diastolic Decreased, Deep Vein Thrombosis, Dizziness, Dyspnoea
Adverse event was reported on Dec 11, 2007 by a Female patient taking Zolinza (View Usage) (Dosage: 400 Mg/daily/po;300 Mg/daily/po) was diagnosed with breast cancer metastatic and. Location: UNITED STATES , 63 years of age, weighting 157.0 lb, After Zolinza was administered, patient had the following side effects: abdominal pain lower, asthenia, back pain (What is back pain?), blood bilirubin increased, blood potassium increased, blood pressure diastolic decreased, deep vein thrombosis (What is deep vein thrombosis?), dizziness (What is dizziness?), dyspnoea. During the same period patient was treated with TAMOXIFEN CITRATE (20 Mg/daily/po) (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ). Patient was hospitalized.

5616191-0 | Cardiac Disorder, Loss Of Consciousness
on Jan 28, 2008 Male patient from UNITED STATES , 77 years of age, was diagnosed with lymphoma (What is lymphoma?) and was treated with Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac disorder, loss of consciousness. Zolinza dosage: . During the same period patient was treated with ACTONEL (View Actonel Review and Actonel Label ), LASIX (View Lasix Review and Lasix Label ), COREG (View Coreg Review and Coreg Label ), VESICARE (View Vesicare Review and Vesicare Label ), RYTHMOL (View Rythmol Review and Rythmol Label ). Patient was hospitalized.

5579934-0 | Abdominal Pain Lower, Back Pain, Blood Bilirubin Increased, Blood Potassium Increased, Deep Vein Thrombosis, Haemoglobin Decreased, Haemolysis, Hypovolaemic Shock, Intra-abdominal Haemorrhage
on Dec 11, 2007 Female patient from UNITED STATES , 63 years of age, weighting 157.0 lb, was diagnosed with breast cancer metastatic and was treated with Zolinza (View Usage). Patient had the following side effects: abdominal pain lower, back pain (What is back pain?), blood bilirubin increased, blood potassium increased, deep vein thrombosis (What is deep vein thrombosis?), haemoglobin decreased, haemolysis, hypovolaemic shock, intra-abdominal haemorrhage. Zolinza dosage: 400 Mg/daily/po, 300 Mg/daily/po. During the same period patient was treated with TAB TAMOXIFEN CITRATE UNK (20 Mg/daily/po) (View Tab Tamoxifen Citrate Unk Review and Tab Tamoxifen Citrate Unk Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ). Patient was hospitalized.

5553356-0 | Back Pain, Blood Bilirubin Increased, Deep Vein Thrombosis, Hypotension, Hypovolaemic Shock, Intra-abdominal Haemorrhage, Pulmonary Embolism, Retroperitoneal Haematoma
Patient was taking Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: back pain (What is back pain?), blood bilirubin increased, deep vein thrombosis (What is deep vein thrombosis?), hypotension, hypovolaemic shock, intra-abdominal haemorrhage, pulmonary embolism (What is pulmonary embolism?), retroperitoneal haematoma on Dec 12, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 157.0 lb, was diagnosed with breast cancer metastatic and. Zolinza dosage: 400mg Daily 21days Of 28 Po. During the same period patient was treated with TAMOXIFEN CITRATE (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ), COMPAZINE (View Compazine Review and Compazine Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), ACIPHEX (View Aciphex Review and Aciphex Label ). Patient was hospitalized.

5531212-1 | Cardio-respiratory Arrest
Adverse event was reported on Nov 27, 2007 by a Male patient taking Zolinza (View Usage) (Dosage: ) was diagnosed with mycosis fungoides and. Location: UNITED STATES , 56 years of age, weighting 167.6 lb, Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest. During the same period patient was treated with GEMCITABINE HYDROCHLORIDE (View Gemcitabine Hydrochloride Review and Gemcitabine Hydrochloride Label ), ADENOSINE (View Adenosine Review and Adenosine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), FLEBOGAMMA (View Flebogamma Review and Flebogamma Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), DIPHENHYDRAMINE HYDROCHLORIDE (View Diphenhydramine Hydrochloride Review and Diphenhydramine Hydrochloride Label ).

5525686-X | Dehydration, Fatigue, Mycosis Fungoides, Nausea
on Nov 12, 2007 Female patient from UNITED STATES , 80 years of age, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). Patient had the following side effects: dehydration, fatigue, mycosis fungoides, nausea (What is nausea?). Zolinza dosage: . During the same period patient was treated with INTERFERON ALFA (View Interferon Alfa Review and Interferon Alfa Label ), TRICOR (View Tricor Review and Tricor Label ).

5524133-1 | Cardio-respiratory Arrest
on Nov 14, 2007 Male patient from UNITED STATES , 56 years of age, weighting 167.6 lb, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: cardio-respiratory arrest. Zolinza dosage: . During the same period patient was treated with GEMCITABINE HYDROCHLORIDE (View Gemcitabine Hydrochloride Review and Gemcitabine Hydrochloride Label ), ADENOSINE (View Adenosine Review and Adenosine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), FLEBOGAMMA (View Flebogamma Review and Flebogamma Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), DIPHENHYDRAMINE HYDROCHLORIDE (View Diphenhydramine Hydrochloride Review and Diphenhydramine Hydrochloride Label ).

5512955-2 | Fatigue, Nausea, Neoplasm
Patient was taking Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, nausea (What is nausea?), neoplasm on Nov 01, 2007 from UNITED STATES Additional patient health information: Female patient , 80 years of age, was diagnosed with mycosis fungoides and. Zolinza dosage: . During the same period patient was treated with INTERFERON ALFA (View Interferon Alfa Review and Interferon Alfa Label ), TRICOR (View Tricor Review and Tricor Label ).

5504785-2 | Activated Partial Thromboplastin Time Shortened, Deep Vein Thrombosis, Prothrombin Time Shortened, Pulmonary Embolism, Thrombocytopenia
Adverse event was reported on Oct 31, 2007 by a Female patient taking Zolinza (View Usage) (Dosage: 400 Mg Daily 21 Of 28 Days P.o. 30 Mg Daily 21 Day Of 28 Days Po) was diagnosed with breast cancer metastatic and. Location: UNITED STATES , 61 years of age, weighting 177.3 lb, Patient had the following side effects: activated partial thromboplastin time shortened, deep vein thrombosis (What is deep vein thrombosis?), prothrombin time shortened, pulmonary embolism (What is pulmonary embolism?), thrombocytopenia. During the same period patient was treated with TAMOXIFEN CITRATE (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ), ZOMETA (View Zometa Review and Zometa Label ), GLUCOSAMINE CHONDROITIN (View Glucosamine Chondroitin Review and Glucosamine Chondroitin Label ).

5491255-3 | Abdominal Discomfort, Fatigue, Osteonecrosis
on Aug 16, 2007 Female patient from UNITED STATES , 68 years of age, was treated with Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: abdominal discomfort, fatigue, osteonecrosis (What is osteonecrosis?). Zolinza dosage: .

5487311-6 | Acute Prerenal Failure, Anaemia, Dehydration, Delirium, Fungal Infection, Hypoventilation, Malaise, Thrombocytopenia
on Oct 12, 2007 Male patient from UNITED STATES , 55 years of age, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: acute prerenal failure, anaemia, dehydration, delirium, fungal infection (What is fungal infection?), hypoventilation, malaise, thrombocytopenia. Zolinza dosage: . Patient was hospitalized.

5485803-7 | Anaemia, Back Pain, Benign Prostatic Hyperplasia, Blood Creatine Phosphokinase Increased, Coagulopathy, Cough, Dehydration, Flank Pain
Patient was taking Zolinza (View Usage). Patient had the following side effects: anaemia, back pain (What is back pain?), benign prostatic hyperplasia, blood creatine phosphokinase increased, coagulopathy, cough, dehydration, flank pain on Oct 03, 2007 from UNITED STATES Additional patient health information: Male patient , 60 years of age, was diagnosed with mycosis fungoides, hyperlipidaemia, hypothyroidism, hypertension and. Zolinza dosage: . During the same period patient was treated with TARGRETIN (View Targretin Review and Targretin Label ), COUMADIN (View Coumadin Review and Coumadin Label ), PAXIL (View Paxil Review and Paxil Label ), RITALIN (View Ritalin Review and Ritalin Label ), MEGACE (View Megace Review and Megace Label ), LIPITOR (View Lipitor Review and Lipitor Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ). Patient was hospitalized.